Skip to NavigationSkip to content

GSK teams up with Strathclyde and University of Nottingham

Published on 16/07/19 at 09:26am

GlaxoSmithKline has teamed up with the University of Nottingham and the University of Strathclyde for a five-year partnership aimed at promoting new medical research.

The £12.9 million project has received £5.5 million in funding from the Engineering and Physical Sciences Research Council (ESPRC).

The partnership will see the three organisations team up to use machine learning and AI to identify new medicines and make the production of medicines more environmentally friendly.  

The project is also intended to train a new cohort of postgraduate students and postdoctoral researchers.

Tony Wood, Senior Vice President, Medicinal Science & Technology at GSK said: “We are delighted with the EPSRC award which recognises the important work being done in collaboration with Nottingham and Strathclyde Universities. 

“Together we are focused on the application of Artificial Intelligence/Machine Learning in synthetic chemistry, a discipline that is central to drug design and development of new medicines. The additional support will enable continued research hopefully delivering efficiency gains that bring meaningful benefit to the discovery of new medicines.” 

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches